Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results
Select data models

Selected data models

You must log in to select data models for download or further analysis.

143 Search results.

LASER ADMINISTRATION FELLOW EYE (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382

- 6/28/17 - 1 form, 2 itemgroups, 10 items, 1 language

Itemgroups: Patient administration, LASER ADMINISTRATION STUDY EYE

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

CONCURRENT OCULAR PROCEDURES (DAY 0 - MONTH 12) CRFs Roche FVF4170G Macular Edema NCT00473382

- 6/11/17 - 1 form, 3 itemgroups, 12 items, 1 language

Itemgroups: Patient administration, CONCURRENT OCULAR PROCEDURES (DAY 0 - MONTH 12), Procedure

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Prior Ocular Therapies And Procedures Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4170g - Prior Ocular Therapies And Procedures Screening

- 3/21/18 - 1 form, 1 itemgroup, 11 items, 1 language

Itemgroup: Therapy diabetes mellitus

Study part: Prior Ocular Therapies And Procedures Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

Prior Ocular Therapies And Procedures Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Prior Ocular Therapies And Procedures Screening

- 3/20/18 - 1 form, 1 itemgroup, 11 items, 1 language

Itemgroup: Therapy diabetes mellitus

Study part: Prior Ocular Therapies And Procedures Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 21) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language

Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 21)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 22) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language

Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 22)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 19) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language

Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 19)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 23) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language

Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 23)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 20) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language

Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 20)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 24) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language

Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 24)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 17) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language

Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 17)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 18) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language

Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 18)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.